Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255294 · ClinicalTrials.gov registry record · Phase 2
Contraceptive Effectiveness Trial of Cellulose Sulfate Gel
A Phase 2 study, sponsored by CONRAD.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00255294 is a Phase 2 study that has completed, run by CONRAD. The registered enrollment target is 200 participants.
The verdict
NCT00255294, a Phase 2 study, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study will evaluate the contraceptive effectiveness of cellulose sulfate vaginal gel in preventing pregnancy when used for 6 months.
Interventions
- DRUG Cellulose sulfate vaginal gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-01 |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00255294
The ClinicalTrials.gov registry entry for NCT00255294 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cellulose sulfate vaginal gel is the first listed.
NCT00255294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00255294 about?
NCT00255294 is a clinical study titled "Contraceptive Effectiveness Trial of Cellulose Sulfate Gel". This study will evaluate the contraceptive effectiveness of cellulose sulfate vaginal gel in preventing pregnancy when used for 6 months.
What is the current status of trial NCT00255294?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2005-01. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00255294?
The interventions under investigation include: Cellulose sulfate vaginal gel (DRUG).
Who is sponsoring clinical trial NCT00255294?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.